Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
| Name | Authors | DOI | Group |
Summary |
Associated Publications |
RRIDs used | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SARS-CoV-2 virus plaque assays [Biosafety Level 3] Resource Report Resource Website |
tenOever Lab | DOI:10.17504/protocols.io.bdtni6me | Coronavirus Method Development Community | Method to plaque the SARS-CoV-2 virus Image attribution:Y tambe / CC BY-SA (http://creativecommons.org/licenses/by-sa/3.0/)Downloaded from: https://commons.wikimedia.org/wiki/File:Plaque_assay_macro.jpg | Icahn School of Medicine at Mount Sinai | https://bit.ly/3d6OUny | 1 | 2020 | tenOever Lab 2020. SARS-CoV-2 virus plaque assays [Biosafety Level 3]. protocols.io https://dx.doi.org/10.17504/protocols.io.bdtni6me | 2021-04-15 09:15:29 | ||
|
AMDx Lateral Flow Assay WIth a Cover Protocol Resource Report Resource Website |
samz | DOI:10.17504/protocols.io.bk54ky8w | Coronavirus Method Development Community, XPRIZE Rapid Covid Testing | American Molecular Dx LLC | 1 | 2020 | samz 2020. AMDx Lateral Flow Assay WIth a Cover Protocol. protocols.io https://dx.doi.org/10.17504/protocols.io.bk54ky8w | 2021-04-15 09:15:03 | ||||
|
Viral RNA extraction low-cost protocol optimized for SARS-Cov2 at AGROSAVIA Resource Report Resource Website |
Alejandro Caro-Quintero, Roxana Yockteng | DOI:10.17504/protocols.io.bggvjtw6 | Coronavirus Method Development Community, Reclone.org (The Reagent Collaboration Network) | Here we present the second version of an RNA extraction protocol for SARs-cov2 using magnetic beads. This protocol was optimized in AGROSAVIA laboratories and is presented as an alternative to the limitations of commercial viral RNA extraction kits. The viral RNA extraction protocol was adapted from the protocol entitled “SARS-CoV-2 RNA purification from nasal / throat swabs collected in Viral Transfer Media” at https://bomb.bio/ and which is based on methods previously reported by the same group (Oberacker et al 2019). The optimized version here achieves Ct results like the commercial kits and reduces the cost of RNA extraction per sample by 90%, that is, 2000 Colombian pesos or 50 cents per sample. We share this protocol in the hope that it can ensure the sustainability of the diagnosis in Colombia and other countries where it is difficult and expensive to import commercial kits.REFERENCESOberacker, P., Stepper, P., Bond, D. M., Höhn, S., Focken, J., Meyer, V., ... & Hore, S. R. (2019). Bio-On-Magnetic-Beads (BOMB): Open platform for high-throughput nucleic acid extraction and manipulation. PLoS biology, 17(1), e3000107.Yu, F., Qiu, T., Zeng, Y., Wang, Y., Zheng, S., Chen, X., & Chen, Y. (2018). Comparative evaluation of three Preprocessing Methods for extraction and detection of Influenza A Virus Nucleic Acids from sputum. Frontiers in Medicine, 5, 56.He, H., Li, R., Chen, Y., Pan, P., Tong, W., Dong, X., ... & Yu, D. (2017). Integrated DNA and RNA extraction using magnetic beads from viral pathogens causing acute respiratory infections. Scientific reports, 7, 45199.Corman, V.M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D.K., Bleicker, T.,Brünink, S., Schneider, J., Schmidt, M.L. and Mulders, D.G., 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance, 25(3).Kumar, M., Mazur, S., Ork, B.L., Postnikova, E., Hensley, L.E., Jahrling, P.B., Johnson, R.and Holbrook, M.R., 2015. Inactivation and safety testing of Middle East respiratory syndrome coronavirus. Journal of virological methods, 223, pp.13-18 | AGROSAVIA/Universidad Nacional de Colombia, AGROSAVIA/Universidad Nacional de Colombia | http://10.13140/RG.2.2.34818.50881 | 1 | 2020 | Alejandro Caro-Quintero, Roxana Yockteng 2020. Viral RNA extraction low-cost protocol optimized for SARS-Cov2 at AGROSAVIA. protocols.io https://dx.doi.org/10.17504/protocols.io.bggvjtw6 | 2021-04-15 09:15:02 | ||
|
RNA Extraction Without a Kit Resource Report Resource Website |
Addgene The Nonprofit Plasmid Repository | DOI:10.17504/protocols.io.beabjaan | Coronavirus Method Development Community | This protocol describes RNA extraction without a kit. To see the full abstract and additional resources, visit https://www.addgene.org/protocols/kit-free-rna-extraction/ | Addgene | https://www.addgene.org/protocols/kit-free-rna-extraction/ | 1 | 2020 | Addgene The Nonprofit Plasmid Repository 2020. RNA Extraction Without a Kit. protocols.io https://dx.doi.org/10.17504/protocols.io.beabjaan | 2021-04-15 09:15:32 | ||
|
covid 19 indirect detection thru rise of 100nm filter fluid resistance Resource Report Resource Website |
Ladislav Nevery | DOI:10.17504/protocols.io.bmazk2f6 | Coronavirus Method Development Community, XPRIZE Rapid Covid Testing, Ladislav Nevery | By passing saliva sample thru 150nm filter to remove particles larger than avg 125nm sized covid 19 virus particles and concentrating resulting fluid to very small 1 mm2 area of 110nm filter. Pores in this small area should be clogged up fast raising filter air/fluid resistance. Due to high virus density 5.2 log10 ml saliva of infected person should clogg filter much faster than healthy person. Test is setup in such way that we let gravity pass 2l of fluid thru clogged filter and record rate of drops from its bottom as audio on mobile phone placed bellow glass cup. rate of drops thru clogged filter should be measurably slower than clean filter. | 4 | 2020 | Ladislav Nevery 2020. covid 19 indirect detection thru rise of 100nm filter fluid resistance. protocols.io https://dx.doi.org/10.17504/protocols.io.bmazk2f6 | 2021-04-15 09:15:33 | ||||
|
XPRIZE SANATA Protocol for Saliva LFIA Test Resource Report Resource Website |
Mario Thomas, Jasmine Sollen, Natalia Ivanova, Michelle Feng, Reda Fayek, Heidi Abdilla, Stephanie Lim, Amanda Naaum, Holly Rumery, Mario Escobar | DOI:10.17504/protocols.io.brgsm3we | Coronavirus Method Development Community, SANATA, InnOvOtion By Holly, InnOvOtion by Holly | This procedure outlines the protocol for testing for SARS-CoV-2 using a saliva sample collected from an individual. The purpose of this test is to detect low levels of SARS-CoV-2 antigen at a higher sensitivity. Precision Biomonitoring Inc. developed an ultra-rapid digital, disposable, highly-sensitive and inexpensive testing device used for screening purposes. The mobile app complementary to this medical device is connected through Bluetooth. Using this innovation, the user can be tested at point-of-care (POC) by a health care professional, and obtain qualitative results. | Precision Biomonitoring Inc., Precision Biomonitoring Inc., Precision Biomonitoring Inc., Precision Biomonitoring Inc., Precision Biomonitoring Inc., Precision Biomonitoring Inc., Precision Biomonitoring Inc., Precision Biomonitoring Inc., Precision Biomonitoring Inc., Precision Biomonitoring Inc. | 1 | 2021 | Mario Thomas, Jasmine Sollen, Natalia Ivanova, Michelle Feng, Reda Fayek, Heidi Abdilla, Stephanie Lim, Amanda Naaum, Holly Rumery, Mario Escobar 2021. XPRIZE SANATA Protocol for Saliva LFIA Test. protocols.io https://dx.doi.org/10.17504/protocols.io.brgsm3we | 2021-04-15 09:15:34 | |||
|
nCoV-2019 sequencing protocol (RAPID barcoding, 1200bp amplicon) Resource Report Resource Website |
Nikki Freed, Olin Silander | DOI:10.17504/protocols.io.bgc8jszw | Coronavirus Method Development Community | To enable faster, easier sequencing of SARS-COV2 genomes with fewer steps than current methods, we use multiplexed 1200 base pair PCR amplicons with the Oxford Nanopore RAPID barcoding kit (RBK004). This is a modification of the ARTIC amplicon V3 sequencing protocol for MinION for nCoV-2019 developed by Josh Quick, which produces 400 base pair amplicons and uses the Oxford Nanopore Ligation barcoding kit (LSK-109). We have increased the size of the amplicons to 1200bp and use the RAPID barcode kit (RBK004), which enables requires less time and fewer reagents than the LSK-109 protocol. The amplicons produced in this protocol could also be used for Illumina sequencing. Primers were all designed using Primal Scheme: http://primal.zibraproject.org/, described here https://www.nature.com/articles/nprot.2017.066.Primer sequences are here: https://docs.google.com/spreadsheets/d/1M5I_C56ZC8_2Ycgm9EFieVlVNqxsP7dXAnGoBZy3nDo/edit?usp=sharingWe can ship a small amount of pooled primers to interested labs for further testing, email [email protected] or [email protected] | Massey University, Massey University | 2 | 2020 | Nikki Freed, Olin Silander 2020. nCoV-2019 sequencing protocol (RAPID barcoding, 1200bp amplicon). protocols.io https://dx.doi.org/10.17504/protocols.io.bgc8jszw | 2021-04-15 09:15:06 | |||
|
SARS-CoV-2 detection using BGI RT-PCR kit Resource Report Resource Website |
Wei-Ting Lu, Ming Jiang, Robert Goldstone, Karen Ambrose, Chris Ekin, Amy Strange, Nnenna Kanu, Paul Grant, Efthymios Fidanis, Jerome Nicod, David Moore, Michael Howell | DOI:10.17504/protocols.io.bfc8jizw | BGI, Coronavirus Method Development Community, Crick COVID-19 Consortium | Purpose of examination / Clinical relevanceAt the end of 2019, several pneumonia cases were reported in Wuhan, China and the pathogen was confirmed as a new viral strain. World Health organization has named the newly identified coronavirus as 2019-nCoV, also known as COVID19. The disease developed into a dangerous pandemic, posing major challenges to the NHS. Although more research is necessary to better understand the virus, in response to the emergency, simple and rapid testing is essential to identify the virus in infected individuals. This will aid the implementation of efficient interventions to contain the spread, and distinguish healthcare workers who have been infected, and are required to self-isolate, from those showing similar symptoms but which are not 2019-nCoV associated. The latter category may continue to work, alleviating stress on hard-pressed healthcare resources. 2019-nCoV is an RNA virus, and the diagnostic tests detect viral RNA in swabs from patient airways using a reverse transcriptase PCR assay. Samples are submitted to HSL, an accredited reporting laboratory, and transferred to the Crick for testing. The first step of the process is sample receipt at the Crick.This protocol describes the preparation of the RT-PCR master mix plate, automated addition of RNA template and the reverse-transcriptase quantitative PCR of viral RNA to detect the Orf1ab region of the viral genome, which has high specificity to the 2019-nCoV virus. Furthermore, the protocol describes the analysis of the COVID-19 test results.Principles of ExaminationThe kit is a qualitative in vitro nucleic acid amplification assay to detect the new coronavirus 2019-nCoV identified in China in 2019 using Reverse transcription PCR of RNA derived from specimen of throat swabs and Bronchoalveolar Lavage Fluid (BALF) from individuals suspected to have been exposed to the virus. The kit is based on in vitro RT-PCR with fluorescent probes. Primers and sequence-specific fluorescence probes were designed tailored to the high conservative ORF1ab region of the 2019-nCoV genome. The probes are oligonucleotides with attached fluorophores at the 5' end (FAM as reporter) and at the 3’ end (quencher). In addition, a specific primer and probe set designed to human b-actin is included as an internal reference with fluorophores VIC/HEX attached at 5’ end as reporter. During the PCR procedure, the DNA polymerase cleaves the probe at the 5’ end and separates the reporter dye from the quencher dye when the probes hybridize to the target DNA. This cleavage results in a fluorescent signal generated by the cleaved reporter dye, which is monitored in real-time by the PCR detection system. Monitoring the fluorescence intensities during Real Time allows the qualitative detection of 2019-nCoV in specimens.Analysis of the COVID19 test results will allow the qualitative detection of the 2019-nCoV nucleic acid in specimens from patients with suspected 2019n-nCoV. This process will enable the assessment of the infection in clinical and public health practice. The workflow for reporting results from this test is illustrated below: | Aitken, J., Ambrose, K., Barrell, S. et al. Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol (2020). https://doi.org/10.1038/s41587-020-0588-y | The Francis Crick Institute, The Francis Crick Institute, The Francis Crick Institute, The Francis Crick Institute, Health Services Laboratories, The Francis Crick Institute, University College London, Health Services Laboratories, The Francis Crick Institute, The Francis Crick Institute, University College London, The Francis Crick Institute | https://doi.org/10.1038/s41587-020-0588-y | 1 | 2020 | Wei-Ting Lu, Ming Jiang, Robert Goldstone, Karen Ambrose, Chris Ekin, Amy Strange, Nnenna Kanu, Paul Grant, Efthymios Fidanis, Jerome Nicod, David Moore, Michael Howell 2020. SARS-CoV-2 detection using BGI RT-PCR kit. protocols.io https://dx.doi.org/10.17504/protocols.io.bfc8jizw | 2021-04-15 09:15:06 | |
|
Automated high throughput viral concentration from wastewater using the KingFisher Flex platform Resource Report Resource Website |
Smruthi Karthikeyan, Greg Humphrey | DOI:10.17504/protocols.io.bptemnje | Coronavirus Method Development Community | Large-scale wastewater surveillance has the ability to greatly augment the tracking of infection dynamics especially in communities where the prevalence rates far exceed the testing capacity. However, current methods for viral detection in wastewater are severely lacking in terms of scaling up for high throughput. In the present study, we employed an automated magnetic-bead based concentration approach for viral detection in sewage that can effectively be scaled up for processing 24 samples in a single 40-minute run. The method compared favorably to conventionally used methods for viral wastewater concentrations with a limit of detection of 8.809 viral gene copies/ml from input sample volumes as low as 10ml and can enable the processing of over 100 wastewater samples in a day. | University of California, San Diego, University of California, San Diego | https://www.medrxiv.org/content/10.1101/2020.11.16.20232900v1 | 1 | 2020 | Smruthi Karthikeyan, Greg Humphrey 2020. Automated high throughput viral concentration from wastewater using the KingFisher Flex platform. protocols.io https://dx.doi.org/10.17504/protocols.io.bptemnje | 2021-04-15 09:15:10 | ||
|
Automated transfer of inactivated virus samples from individual 2ml tubes to 96-well plate Resource Report Resource Website |
Efthymios Fidanis, Sophia Ward, Laura Cubitt, Amelia Edwards, Debbie Hughes, Michael Hubank, Jerome Nicod | DOI:10.17504/protocols.io.bfb2jiqe | Coronavirus Method Development Community, Crick COVID-19 Consortium | Purpose of examination / Clinical relevanceAt the end of 2019, several pneumonia cases were reported in Wuhan, China and the pathogen was confirmed as a new viral strain. World Health organization has named the newly identified coronavirus as 2019-nCoV, also known as SARS-Cov-2. The disease developed into a dangerous pandemic, posing major challenges to the NHS. Although more research is necessary to better understand the virus, in response to the emergency, simple and rapid testing is essential to identify the virus in infected individuals. This will aid the implementation of efficient interventions to contain the spread, and distinguish healthcare workers who have been infected, and are required to self-isolate, from those showing similar symptoms but which are not 2019-nCoV associated. The latter category may continue to work, alleviating stress on hard-pressed healthcare resources. 2019-nCoV is an RNA virus, and the diagnostic tests detect viral RNA in swabs from patient airways using a reverse transcriptase PCR assay. Samples are submitted to HSL, an accredited reporting laboratory, and transferred to the Crick for testing. The first step of the process is sample receipt at the Crick. This SOP describes the transfer of inactivated virus into plates for RNA extraction.Principles of ExaminationThe assay uses the Hamilton robot to transfer 150 μl of 93 samples of inactivated viral media samples from Barcoded 2 ml tubes (Cat no. 72.694.005) to Barcoded 96 well Nunc plates (Cat no. 260251) maintaining sample identity.--The authors wish to thank Heather Ringrose for support with the Hamilton liquid handlingworkstation. | Aitken, J., Ambrose, K., Barrell, S. et al. Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol (2020). https://doi.org/10.1038/s41587-020-0588-y | The Francis Crick Institute, The Francis Crick Institute, The Francis Crick Institute, The Francis Crick Institute, The Institute of Cancer Research, The Royal Marsden Hospital, The Institute of Cancer Research, The Royal Marsden Hospital, The Francis Crick Institute | https://doi.org/10.1038/s41587-020-0588-y | 1 | 2020 | Efthymios Fidanis, Sophia Ward, Laura Cubitt, Amelia Edwards, Debbie Hughes, Michael Hubank, Jerome Nicod 2020. Automated transfer of inactivated virus samples from individual 2ml tubes to 96-well plate. protocols.io https://dx.doi.org/10.17504/protocols.io.bfb2jiqe | 2021-04-15 09:15:11 | |
|
MERS-CoV Spike Glycoprotein (GP) – ELISA Jenner Clinical SOP Template Resource Report Resource Website |
Mustapha Bittaye, Sarah Gilbert, Katie Ewer, Teresa Lambe | DOI:10.17504/protocols.io.bgr6jv9e | Coronavirus Method Development Community | This Standard Operating Procedure (SOP) describes the techniques used to measure the titres of total human immunoglobulin G (IgG) responses against a full length recombinant clamped MERS-CoV spike glycoprotein (GP) in human plasma and serum samples. The measured antibody titres will serve to indicate the humoral immune response to a candidate ChAdOx1 MERS vaccine encoding the full length spike GP of the MERS-CoV in human subjects. This assay must be performed in accordance with the principles of the International Conference on Harmonisation Tripartite Guideline on Good Clinical Practice and the Human Tissue Act. Informed consent must be in place for samples to be tested in this assay. | The Jenner Institute, University of Oxford, The Jenner Institute, University of Oxford, The Jenner Institute, University of Oxford, The Jenner Institute, University of Oxford | 1 | 2020 | Mustapha Bittaye, Sarah Gilbert, Katie Ewer, Teresa Lambe 2020. MERS-CoV Spike Glycoprotein (GP) – ELISA Jenner Clinical SOP Template. protocols.io https://dx.doi.org/10.17504/protocols.io.bgr6jv9e | 2021-04-15 09:15:12 | |||
|
RT-LAMP SARS-CoV-2 positive control stock Resource Report Resource Website |
Christina Newman, Andrea Weiler, Dawn Dudley, Mitchell Ramuta, Amelia Haj, Shelby O'Connor, David O'Connor | Coronavirus Method Development Community | University of Wisconsin-Madison, University of Wisconsin-Madison, University of Wisconsin-Madison, University of Wisconsin-Madison, University of Wisconsin-Madison, University of Wisconsin-Madison, University of Wisconsin-Madison | 1 | 2020 | Christina Newman, Andrea Weiler, Dawn Dudley, Mitchell Ramuta, Amelia Haj, Shelby O'Connor, David O'Connor 2020. RT-LAMP SARS-CoV-2 positive control stock. protocols.io https:// | 2021-04-15 09:15:37 | |||||
|
Quality Assurance and Quality Control (Part 10 of Phase 3 study of Vaccine Candidate for COVID-19) Resource Report Resource Website |
Chris Ockenhouse, Chris Gast, Renee Holt, Jorge Flores | DOI:10.17504/protocols.io.bj57kq9n | Coronavirus Method Development Community, PATH | This is Part 10 of "Phase 3 randomized, double-blinded, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of Vaccine Candidate against COVID-19 in adults > 18 years of age"This generic Phase 3 protocol was developed by the PATH team with support of the Bill and Melinda Gates Foundation. The aim of the collection is to share recommended best practices in designing and implementing a Phase 3 study of a COVID-19 vaccine candidate. As Phase 3 trials of different Vaccine Candidates proceed around the world, following the same protocols will ensure consistency and comparability of the Phase 3 trial results.Please note that this is an evolving document, to be versioned and updated, based on community feedback and new data. | Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington) | 1 | 2020 | Chris Ockenhouse, Chris Gast, Renee Holt, Jorge Flores 2020. Quality Assurance and Quality Control (Part 10 of Phase 3 study of Vaccine Candidate for COVID-19). protocols.io https://dx.doi.org/10.17504/protocols.io.bj57kq9n | 2021-04-15 09:15:41 | |||
|
SalivaDirect™: RNA extraction-free SARS-CoV-2 diagnostics Resource Report Resource Website |
Chantal Vogels, Doug E. Brackney, Chaney Kalinich, Isabel Ott, Nathan Grubaugh, Anne Wyllie | DOI:10.17504/protocols.io.bkjgkujw | Coronavirus Method Development Community | SalivaDirect™ is an RNA-extraction free, dual-plexed RT-qPCR method for SARS-CoV-2 detection. It can be broadly implemented as it (1) does not require saliva collection tubes containing preservatives, (2) does not require specialized equipment for RNA extraction, and (3) is validated for use with products from multiple vendors. Thus, the simplicity and flexibility of SalivaDirect™ means that it is not as affected by supply chain bottlenecks as some other assays. Our method is RNA-extraction free which enables testing of low volume and minimally processed saliva in dual-plexed RT-qPCR for SARS-CoV-2 detection. Saliva will be treated with proteinase K followed by a heat inactivation step, and is then directly used as input in the dual-plexed RT-qPCR test. Our aim was not to design new primers and probes for RT-qPCR testing, but rather to use validated primer and probe sets (N1 and RP) developed by the US CDC. The human Ribonuclease P (RP) probe was modified with a different fluorophore so that the primer/probe set could be combined in a dualplex assay, reducing the number of tests to 1 assay with 2 sets.Version 2 includes: Optimized thermocycler conditionsLocally validated alternative options for Proteinase K, RT-qPCR master mix, and thermocyclersUse of 8-strip tubes for sample processing step, due to contamination issues in 96-well plates.Version 3 has been updated to remove steps for sample self-collection.Version 4 has updated Ct thresholds for the ABI 7500 Fast Dx.Version 5 has an updated description for use, additional RP probe with ATTO647 fluorophore, and a detailed table with catalog numbers. | Vogels CB, Watkins AE, Harden CA, Brackney DE, Shafer J, Wang J, Caraballo C, Kalinich CC, Ott IM, Fauver JR, Kudo E, Lu P, Venkataraman A, Tokuyama M, Moore AJ, Muenker MC, Casanovas-Massana A, Fournier J, Bermejo S, Campbell M, Datta R, Nelson A, , Cruz CSD, Ko AI, Iwasaki A, Krumholz HM, Matheus J, Hui P, Liu C, Farhadian SF, Sikka R, Wyllie AL, Grubaugh ND, SalivaDirect: A Simplified and Flexible Platform to Enhance SARS-CoV-2 Testing Capacity. Med (New York, N.y.) doi: 10.1016/j.medj.2020.12.010 | Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Department of Environmental Sciences The Connecticut Agricultural Experiment Station; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Department of Epidemiology of Microbial Diseases, Yale School of Public Health | https://covidtrackerct.com/about-salivadirect/ | 5 | 2020 | Chantal Vogels, Doug E. Brackney, Chaney Kalinich, Isabel Ott, Nathan Grubaugh, Anne Wyllie 2020. SalivaDirect™: RNA extraction-free SARS-CoV-2 diagnostics. protocols.io https://dx.doi.org/10.17504/protocols.io.bkjgkujw | 2021-04-15 09:15:19 | |
|
Wastewater Concentration by Adsorption and Direct Extraction for SARS-CoV-2 RNA Detection and Quantification using RT-ddPCR Resource Report Resource Website |
Aaron Bivins, Warish Ahmed, Devin North, Kyle Bibby | DOI:10.17504/protocols.io.bhiuj4ew | Coronavirus Method Development Community, 2019-nCoV Wastewater Epidemiology | The following protocol describes the GERM Lab workflow for processing wastewater for SARS-CoV-2 via pH adjustment, MCE filtration, extraction, and assay by droplet digital PCR (ddPCR). It is synonymous to method A as described in Ahmed et al. 2020 (the referenced manuscript) with modifications to the consumables and PCR format. It is intended for use in a BSL2+ lab with extra precautions for processing environmental specimens for SARS-CoV-2 as described in the CDC Interim Laboratory Biosafety Guidelines. | University of Notre Dame, CSIRO, University of Notre Dame, University of Notre Dame | https://www.sciencedirect.com/science/article/pii/S004896972033480X | 2 | 2020 | Aaron Bivins, Warish Ahmed, Devin North, Kyle Bibby 2020. Wastewater Concentration by Adsorption and Direct Extraction for SARS-CoV-2 RNA Detection and Quantification using RT-ddPCR. protocols.io https://dx.doi.org/10.17504/protocols.io.bhiuj4ew | 2021-04-15 09:15:24 | ||
|
High-Throughput Tiled Amplicon Sequencing of Sars-CoV2 using Seqwell's plexWell 384 Resource Report Resource Website |
Megan Folkerts, mnguyen , Danielle Vazquez, Amber Jones | DOI:10.17504/protocols.io.bnkimcue | Coronavirus Method Development Community | Translational Genomics Research Institute, Flagstaff AZ, Translational Genomics Research Institute, Flagstaff AZ, Translational Genomics Research Institute, Flagstaff AZ, Translational Genomics Research Institute, Flagstaff AZ | 1 | 2020 | Megan Folkerts, mnguyen , Danielle Vazquez, Amber Jones 2020. High-Throughput Tiled Amplicon Sequencing of Sars-CoV2 using Seqwell's plexWell 384. protocols.io https://dx.doi.org/10.17504/protocols.io.bnkimcue | 2021-04-15 09:15:24 | ||||
|
IgG expression and purification Resource Report Resource Website |
Bei Wang, Wen-Hsin Sandy Lee, Helen Huang, Patricia Ng, Eve Ngoh, Chia Yin Lee, Hwee Ching Tan, Rabiatul Adawiyah, Mun Kuen Soh, Frannie Teo, Yvonne Yeap, Yuanyu Hu, Cheng-I Wang | DOI:10.17504/protocols.io.bitvken6 | Coronavirus Method Development Community | Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore, Singapore Immunology Network, A*STAR, Singapore | 1 | 2020 | Bei Wang, Wen-Hsin Sandy Lee, Helen Huang, Patricia Ng, Eve Ngoh, Chia Yin Lee, Hwee Ching Tan, Rabiatul Adawiyah, Mun Kuen Soh, Frannie Teo, Yvonne Yeap, Yuanyu Hu, Cheng-I Wang 2020. IgG expression and purification. protocols.io https://dx.doi.org/10.17504/protocols.io.bitvken6 | 2021-04-15 09:15:49 | ||||
|
Validation of Selected RNA Extraction Method Resource Report Resource Website |
Ariel Cerda, Catalina Ibarra-Henriquez, Valentina Sebastian, Grace Armijo, Liliana Lamig, Carolina Miranda, Marcela Lagos, Sandra Solari, Ana María Guzmán, Teresa Quiroga, Susan Hitschfeld, Eleodoro Riveras, Marcela Ferres, Rodrigo A. Gutiérrez, Patricia García, Aniela Wozniak | Coronavirus Method Development Community, Reclone.org (The Reagent Collaboration Network) | FONDAP Center for Genome Regulation. Millennium Institute for Integrative Biology (iBio), Departamento de Genética Molecular y Microbiología, Pontificia Universidad Católica de Chile, Santiago, 8331150, Chile, FONDAP Center for Genome Regulation. Millennium Institute for Integrative Biology (iBio), Departamento de Genética Molecular y Microbiología, Pontificia Universidad Católica de Chile, Santiago, 8331150, Chile, Laboratorio de Microbiología. Servicio de laboratorios Clínicos. Red de Salud UC-CHRISTUS, FONDAP Center for Genome Regulation. Millennium Institute for Integrative Biology (iBio), Departamento de Genética Molecular y Microbiología, Pontificia Universidad Católica de Chile, Santiago, 8331150, Chile, FONDAP Center for Genome Regulation. Millennium Institute for Integrative Biology (iBio), Departamento de Genética Molecular y Microbiología, Pontificia Universidad Católica de Chile, Santiago, 8331150, Chile, Laboratorio de Microbiología. Servicio de laboratorios Clínicos. Red de Salud UC-CHRISTUS, Departamento de Laboratorios Clínicos. Escuela de Medicina. Facultad de Medicina. Pontificia Universidad Católica de chile, Departamento de Laboratorios Clínicos. Escuela de Medicina. Facultad de Medicina. Pontificia Universidad Católica de chile, Departamento de Laboratorios Clínicos. Escuela de Medicina. Facultad de Medicina. Pontificia Universidad Católica de chile, Departamento de Laboratorios Clínicos. Escuela de Medicina. Facultad de Medicina. Pontificia Universidad Católica de chile, FONDAP Center for Genome Regulation. Millennium Institute for Integrative Biology (iBio), Departamento de Genética Molecular y Microbiología, Pontificia Universidad Católica de Chile, Santiago, 8331150, Chile, FONDAP Center for Genome Regulation. Millennium Institute for Integrative Biology (iBio), Departamento de Genética Molecular y Microbiología, Pontificia Universidad Católica de Chile, Santiago, 8331150, Chile, Departamento de Laboratorios Clínicos. Escuela de Medicina. Facultad de Medicina. Pontificia Universidad Católica de chile, FONDAP Center for Genome Regulation. Millennium Institute for Integrative Biology (iBio), Departamento de Genética Molecular y Microbiología, Pontificia Universidad Católica de Chile, Santiago, 8331150, Chile, Departamento de Laboratorios Clínicos. Escuela de Medicina. Facultad de Medicina. Pontificia Universidad Católica de chile, Departamento de Laboratorios Clínicos. Escuela de Medicina. Facultad de Medicina. Pontificia Universidad Católica de chile | https://doi.org/10.1101/2020.05.07.083048 | 1 | 2020 | Ariel Cerda, Catalina Ibarra-Henriquez, Valentina Sebastian, Grace Armijo, Liliana Lamig, Carolina Miranda, Marcela Lagos, Sandra Solari, Ana María Guzmán, Teresa Quiroga, Susan Hitschfeld, Eleodoro Riveras, Marcela Ferres, Rodrigo A. Gutiérrez, Patricia García, Aniela Wozniak 2020. Validation of Selected RNA Extraction Method. protocols.io https:// | 2021-04-15 09:15:26 | ||||
|
Nucleic acid extraction - RNeasy PowerMicrobiome Kit (Qiagen) Resource Report Resource Website |
Adélaïde Roguet, Shuchen Feng | DOI:10.17504/protocols.io.bpg5mjy6 | Coronavirus Method Development Community, mclellan lab | UWM, UWM | 2 | 2021 | Adélaïde Roguet, Shuchen Feng 2021. Nucleic acid extraction - RNeasy PowerMicrobiome Kit (Qiagen). protocols.io https://dx.doi.org/10.17504/protocols.io.bpg5mjy6 | 2021-04-15 09:15:25 | ||||
|
Integrated Virus Detection System - sample collection - prep - processing Resource Report Resource Website |
mrwick | DOI:10.17504/protocols.io.bktkkwkw | Coronavirus Method Development Community, XPRIZE Rapid Covid Testing, BVS, Inc, mrwick | IVDS is uniquely suited to large volume sampling.Collection from saliva or sputum are straightforward – collection in disposable pipette and transfer to a small vial, dilute as needed, filter, and test, all at under 5 minutes including results.Sample collection, storage and processing are straightforward, not requiring sensitive or unstable solutions. | BVS, Inc | 2 | 2020 | mrwick 2020. Integrated Virus Detection System - sample collection - prep - processing. protocols.io https://dx.doi.org/10.17504/protocols.io.bktkkwkw | 2021-04-15 09:15:31 |
Can't find your Protocol?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific protocol and you know the DOI of the protocol already, it's easier to enter a DOI to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your protocol in the search results, please help us by adding it into the system — it's easy. Create and publish your protocols at Protocols.io.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
